These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
96 related items for PubMed ID: 4880441
1. The lung as a metabolic organ. Said SI. N Engl J Med; 1968 Dec 12; 279(24):1330-4. PubMed ID: 4880441 [No Abstract] [Full Text] [Related]
2. Abnormalities in lung chemistry. Darrah HK, Hedley-Whyte J. Anesth Analg; 1969 Dec 12; 48(1):148-65. PubMed ID: 5812550 [No Abstract] [Full Text] [Related]
3. [Metabolism of vasoactive substances in the lung]. Kokubu T, Ueda E, Akutsu H, Ito T. Nihon Rinsho; 1971 Dec 12; 29(12):3051-60. PubMed ID: 4335196 [No Abstract] [Full Text] [Related]
4. Metabolic activity of the lung and its role in pulmonary disease. Said SI. Clin Notes Respir Dis; 1971 Dec 12; 10(3):3-9. PubMed ID: 4943488 [No Abstract] [Full Text] [Related]
5. [Vasoactive substance and the lung]. Kitamura S. Kokyu To Junkan; 1973 Aug 12; 21(8):688-700. PubMed ID: 4354545 [No Abstract] [Full Text] [Related]
6. Metabolic functions of the pulmonary circulation. Said SI. Circ Res; 1982 Mar 12; 50(3):325-33. PubMed ID: 6174252 [No Abstract] [Full Text] [Related]
7. [Metabolic management of the lung. Functional prerequisites]. von Wichert P. Fortschr Med; 1973 Apr 26; 91(12):541-2. PubMed ID: 4702404 [No Abstract] [Full Text] [Related]
8. [Pulmonary surfactants]. Zapletal A. Cesk Pediatr; 1970 Oct 26; 25(10):489-93. PubMed ID: 4920231 [No Abstract] [Full Text] [Related]
9. [Inactivation of vasoactive substances in the canine lung]. Wagai F, Uetsuka N, Kinoshita M, Watanabe H, Kitamura S. Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Nov 26; 23(11):1337-42. PubMed ID: 4094215 [No Abstract] [Full Text] [Related]
10. [Metabolic function of the lung]. Biron P. Union Med Can; 1968 Jan 26; 97(1):3. PubMed ID: 5652324 [No Abstract] [Full Text] [Related]
12. The effect of shock on pulmonary alveolar surfactant. Its role in refractory respiratory insufficiency of the critically ill or severely injured patient. Henry JN. J Trauma; 1968 Sep 26; 8(5):756-73. PubMed ID: 5675600 [No Abstract] [Full Text] [Related]
14. [Lipids in the lungs and alveolar surfactant in anaphylactic shock]. Bashmakov IuK, Briuzgina TS. Fiziol Zh (1978); 1990 Dec 26; 36(1):87-90. PubMed ID: 2323452 [Abstract] [Full Text] [Related]
15. Metabolism of vasoactive hormones by lung. Gillis CN. Anesthesiology; 1973 Dec 26; 39(6):626-32. PubMed ID: 4148583 [No Abstract] [Full Text] [Related]
16. Handling of bioactive materials by the lung (first of two parts). Fishman AP, Pietra GG. N Engl J Med; 1974 Oct 24; 291(17):884-9. PubMed ID: 4606604 [No Abstract] [Full Text] [Related]
17. [Metabolism of phospholipids of the pulmonary surfactant system]. Barusco G, Curri D. Acta Anaesthesiol; 1971 Oct 24; 22(6):523-32. PubMed ID: 5172565 [No Abstract] [Full Text] [Related]
18. Pulmonary blood flow and the incorporation of palmitate-I-C14 by dog lung in vivo. Naimark A. J Appl Physiol; 1966 Jul 24; 21(4):1292-8. PubMed ID: 5916665 [No Abstract] [Full Text] [Related]